Oscar Health, Inc. (NYSE:OSCR) Receives Average Rating of “Moderate Buy” from Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been given an average recommendation of “Moderate Buy” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $24.00.

A number of analysts have issued reports on the company. Piper Sandler reaffirmed an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group initiated coverage on shares of Oscar Health in a research note on Monday. They issued a “neutral” rating and a $23.00 price target on the stock.

Oscar Health Trading Down 4.6 %

Shares of OSCR opened at $17.34 on Friday. The stock has a 50-day simple moving average of $19.00 and a 200-day simple moving average of $18.12. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health has a 1 year low of $4.72 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.07) EPS. As a group, equities analysts forecast that Oscar Health will post 0.01 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Ranmali Bopitiya sold 36,175 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $650,788.25. Following the completion of the transaction, the executive vice president now owns 251,885 shares in the company, valued at $4,531,411.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 169,569 shares of company stock worth $3,007,069. 25.11% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Several institutional investors have recently modified their holdings of OSCR. Avalon Trust Co acquired a new stake in shares of Oscar Health in the first quarter valued at approximately $69,000. Point72 Hong Kong Ltd acquired a new stake in shares of Oscar Health during the second quarter valued at $78,000. Quest Partners LLC purchased a new stake in Oscar Health during the 2nd quarter worth about $93,000. Amalgamated Bank raised its stake in Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Farallon Capital Management LLC acquired a new stake in shares of Oscar Health during the 1st quarter worth about $164,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.